Hypertrophic cardiomyopathy in China: From bench to bedside

International Journal of Cardiology

Volumn 130, Issue 2, 2008, Pages 121-124

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; CHINESE; COLOR ULTRASOUND FLOWMETRY; DISEASE SEVERITY; EDITORIAL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; M MODE ECHOCARDIOGRAPHY; MYOMECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

BIOMEDICAL RESEARCH; CARDIOMYOPATHY, HYPERTROPHIC; CHINA; HUMANS; POINT-OF-CARE SYSTEMS;

EID: 54949091467     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.062     Document Type: Editorial

References (42)

1. Cheng T.O. Hypertrophic cardiomyopathy is a global disease including China. Int J Cardiol 127 (2008) 1-4
2. Cheng T.O. Cardiology in People's Republic of China-Paul D. White lecture. In: Russek H.I. (Ed). New horizons in cardiovascular practice (1975), University Park Press, Baltimore 1-27
3. Cheng T.O. Hypertrophic cardiomyopathy in China: three decades of progress. Int J Cardiol 100 (2005) 493-494
4. Shanghai First Medical University Zhong Shan Hospital and Shanghai Institute of Cardiovascular Diseases. Clinical investigation of 74 cases of primary cardiomyopathy: II. Obstructive and restrictive primary cardiomyopathy. Chin J Intern Med 16 (1977) 340-346
5. Fang W.H., Guo H.S., Tao P., Wang S.H., Cardiovascular Institute, and Chinese Academy of Medical Sciences. Discussion about some questions on the diagnosis of hypertrophic cardiomyopathy. An analysis of 44 cases of angiographically confirmed cases. Chin J Intern Med 21 (1982) 596-599
6. Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology: a report of 3rd Chinese Conference on Myocarditis and Cardiomyopathy. Chin J Cardiol 35 (2007) 3-4
7. Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology, "Consensus on Diagnosis and Treatment of Cardiomyopathies" Chinese Expert Panel: Recommendations on diagnosis and treatment of cardiomyopathies. Chin J Cardiol 35 (2007) 5-16
8. Maron B.J. Hypertrophic cardiomyopathy: an important global disease. Am J Med 116 (2004) 63-66
9. Maron B.J. Hypertrophic cardiomyopathy in China. Am J Cardiol 100 (2007) 145-146
10. Cheng T.O. William Dock. Am J Cardiol 84 (1999) 1215-1225
11. Hui R.T. Contemporary diagnosis and treatment of hypertrophic cardiomopathy. Chin J Cardiol 35 (2007) 82-85
12. Cheng T.O. The evolution of cardiology in China. In: Wan S., and Yim A.P.C. (Eds). Cardiothoracic Surgery in China: Past, Present and Future (2007), The Chinese University Press, Hong Kong 204-305
13. X.F. Wang, R.T. Sheng: Clinical application of ultrasonic cardiography - recording methodology. Corpus of Ultrasonic Thesis, edited by Wuhan Branch of Chinese Medical Association. 1963:21-25.
14. Gao Y., Wang X.F., Gao R.Y., et al. Characteristics of normal ultrasonic cardiogram and its changes in patients with mitral stenosis. Chin J Intern Med 13 (1965) 710-714
15. Wang X.F., and Xiao J.P. The use of fetal echocardiography for pregnancy diagnosis. Chin J Obstet Gynecol 109 (1964) 267-269
16. Winsberg F. Echocardiography of the fetal and newborn heart. Invest Radiol 7 (1972) 152-158
17. Wang X.F., Wang J., Huang Y., and Cai C. Contrast echocardiography with hydrogen peroxide. I. Experimental study. Chin Med J 92 (1979) 595-599
18. Wang X.F., Wang J.E., Lu C.F., Chen H.R., and Huang Y.Z. Contrast echocardiography with hydrogen peroxide. II. Clinical application. Chin Med J 92 (1979) 693-702
19. Wang X.F., Wang J.E., Lu C.F., Chen H.R., and Huang Y.Z. Contrast echocardiography with hydrogen peroxide in identifying cardiac anatomic structures. Acta Academiae Medicinae Wuhan 6 (1978) 36-39
20. Hsu C.C. Ultrasonic diagnostics (1961), Shang Sci Tech Press 167
21. Hsu C.C. Preliminary studies on ultrasonics in cardiological diagnosis. I. Experimental observations on cardiac echo valves. II. The use of A-scope ultrasound apparatus in the diagnosis of heart disease. Acta Acad Med Prim Shanghai 2 (1964) 251
22. Wang X.F., Wang J.E., and First Hospital of Wuhan Medical College. The use of ultrasound in diagnosis of pericardial effusion. Chin Med J 7 (1973) 411-414
23. Feigenbaum H., Waldhausen J.A., and Hyde L.P. Ultrasound diagnosis of pericardial effusion. JAMA 191 (1965) 711-714
24. Xie M.X., Wang X.F., Cheng T.O., Lu Q., Yuan L., and Liu X. Real-time three-dimensional echocardiography: A review of the development of the technology and its clinical application. Progr Cardiovasc Dis 48 (2005) 209-225
25. Cheng T.O. Clinical application of real-time three-dimensional echocardiography. J Cardiol 49 (2007) 213-214
26. Xiong R.Q., Xie M.X., Wang X.F., et al. Clinical study of assessing myocardial dyssynchrony contraction in patients with hypertrophic cardiomyopathy by tissue synchronization imaging. Chin J Ultrasonogr 15 (2006) 164-167
27. Xiong R.Q., Xie M.X., Wang X.F., and Lu Q. Assessment of regional myocardial function in patients with hypertrophic cardiomyopathy by tissue strain imaging. J Huazhong Univ Sci Technol 26 (2006) 334-337
28. Xie M.X., Zhang L., Lu Q., et al. Left ventricular rotation and twist in patients with hypertrophic cardiomyopathy evaluated by two-dimensional ultrasound speckle-tracking imaging. Acta Acad Med Sin 30 (2008) 58-62
29. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346 (1995) 211-214
30. Li Z.Q., Cheng T.O., Liu L., et al. Experimental study of relationship between intracoronary alcohol injection and the size of resultant infarct. Int J Cardiol 91 (2003) 93-96
31. Li Z.Q., Cheng T.O., Zhang W.W., et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. The Chinese experience in 119 patients from a single center. Int J Cardiol 93 (2004) 197-202
32. He Y.H., Li Z.A., Zhang Y., Lu Z.L., and Yang Y. The value of myocardial contrast echocardiography in transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Chin J Ultrasound 2 (2005) 337-339
33. Dong J., He X.Z., Zhang Y.X., Wu C.Q., Zhang J.X., and Zhang P.Y. Effect of echocardiography in percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy. Clinical Focus 21 (2006) 308-311
34. Tang H.L., Zhao B.W., Fu G.S., et al. Application of quantitative tissue velocity imaging in percutaneous transluminal septal myocardial ablation of hypertrophic obstructive cardiomyopathy. Chin J Ultrasonogr 16 (2007) 829-831
35. Cai J.H., Su X., Zhu H.D., and Zheng Q.T. Percutaneous transluminal septal myocardial ablation in 60 patients with hypertrophic obstructive cardiomyopathy: immediate and followup results. J Clin Cardiol (China) 23 (2007) 488-490
36. Lin L., Zhang C.L., and Fu L. Advances in treatment of hyertrophic obstrutive cardiomyopathy by percutaneous transluminal septal myocardial ablation. Adv Cardiovasc Dis 28 (2007) 288-289
37. Ren R., Xie J., and Du S.R. Hypertrophic obstrutive cardiomyopathy treated by percutaneous transluminal septal myocardial ablation: results and discussion. Gansu Science and Technology 23 (2007) 205-206
38. Zhang T., Ma X.J., and Ren S.T. W: Echocardiographic value in patients with hypertrophic obstructive cardiomyopathy. J Clin Cardiol (China) 23 (2007) 616-617
39. Maron B.J. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severe symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 116 (2007) 196-206
40. Maron B.J., Ommen S.R., Nishimura R.A., and Dearani J.A. Myths about surgical myectomy: rumors of its death have been greatly exaggerated. Am J Cardiol 101 (2008) 887-889
41. Zhu Y.B., Rajan S., Kurian V.M., and Liu Z.Y. Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy. J Zhejiang Univ Sci B 7 2 (2006) 148-153
42. Maron B.J. Hypertrophic cardiomyopathy. A systematic review. JAMA 287 (2002) 1308-1320